- Home
- KROS vs DDI Comparison
KROS vs DDI Comparison
Compare KROS & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- DDI
- Stock Information
- Founded
- KROS 2015
- DDI 2008
- Country
- KROS United States
- DDI South Korea
- Employees
- KROS N/A
- DDI N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- DDI EDP Services
- Sector
- KROS Health Care
- DDI Technology
- Exchange
- KROS Nasdaq
- DDI Nasdaq
- Market Cap
- KROS 565.0M
- DDI 472.2M
- IPO Year
- KROS 2020
- DDI 2021
- Fundamental
- Price
- KROS $15.66
- DDI $9.27
- Analyst Decision
- KROS Buy
- DDI Strong Buy
- Analyst Count
- KROS 14
- DDI 5
- Target Price
- KROS $20.56
- DDI $19.60
- AVG Volume (30 Days)
- KROS 430.7K
- DDI 49.7K
- Earning Date
- KROS 11-05-2025
- DDI 11-10-2025
- Dividend Yield
- KROS N/A
- DDI N/A
- EPS Growth
- KROS N/A
- DDI N/A
- EPS
- KROS 0.47
- DDI 2.15
- Revenue
- KROS $232,844,000.00
- DDI $333,256,000.00
- Revenue This Year
- KROS $5,579.44
- DDI $16.04
- Revenue Next Year
- KROS N/A
- DDI $6.72
- P/E Ratio
- KROS $33.65
- DDI $4.32
- Revenue Growth
- KROS 85820.30
- DDI 0.24
- 52 Week Low
- KROS $9.12
- DDI $8.09
- 52 Week High
- KROS $72.37
- DDI $18.21
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- DDI 40.23
- Support Level
- KROS $15.23
- DDI $9.37
- Resistance Level
- KROS $15.85
- DDI $9.74
- Average True Range (ATR)
- KROS 0.52
- DDI 0.24
- MACD
- KROS 0.01
- DDI -0.02
- Stochastic Oscillator
- KROS 72.91
- DDI 4.40
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.